The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

As we head into 2026, Wolfson Brands’ Tony Stevens has identified the top and most effective male fat burner supplements available from the company's line up.

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) ...

Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the party over?

Some of the healthiest soups include lentil, miso, chicken noodle, minestrone, and other soups that pack in protein, fiber, ...

Medicare beneficiaries with obesity or overweight will have access to Zepbound and orforglipron, if approved, at $50 a month  INDIANAPOLIS, Nov. 6, 2025 ...

This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Bone Loss? Key takeaways: Taking Ozempic® may ...

The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.